Jane Street Group LLC purchased a new position in shares of Ingevity Corp (NYSE:NGVT) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,226 shares of the company’s stock, valued at approximately $261,000.
Several other large investors have also recently made changes to their positions in the company. BlackRock Inc. boosted its stake in shares of Ingevity by 7.8% during the 2nd quarter. BlackRock Inc. now owns 5,985,960 shares of the company’s stock worth $484,025,000 after acquiring an additional 431,313 shares in the last quarter. FMR LLC boosted its stake in shares of Ingevity by 240.1% during the 2nd quarter. FMR LLC now owns 866,464 shares of the company’s stock worth $70,062,000 after acquiring an additional 611,676 shares in the last quarter. Federated Investors Inc. PA boosted its stake in shares of Ingevity by 30.5% during the 2nd quarter. Federated Investors Inc. PA now owns 554,127 shares of the company’s stock worth $44,807,000 after acquiring an additional 129,617 shares in the last quarter. OppenheimerFunds Inc. boosted its stake in shares of Ingevity by 12.4% during the 2nd quarter. OppenheimerFunds Inc. now owns 469,269 shares of the company’s stock worth $37,944,000 after acquiring an additional 51,632 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Ingevity by 9.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 464,076 shares of the company’s stock worth $34,198,000 after acquiring an additional 40,915 shares in the last quarter. 92.04% of the stock is currently owned by institutional investors and hedge funds.
NGVT stock opened at $88.63 on Friday. Ingevity Corp has a 1 year low of $66.57 and a 1 year high of $106.59. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.48 and a current ratio of 2.58. The company has a market capitalization of $3.78 billion, a P/E ratio of 34.78, a P/E/G ratio of 2.01 and a beta of 1.22.
Several equities research analysts have recently commented on NGVT shares. Loop Capital boosted their price target on Ingevity to $89.00 and gave the stock a “$90.05” rating in a research note on Wednesday, July 18th. They noted that the move was a valuation call. Berenberg Bank started coverage on Ingevity in a research note on Thursday, July 12th. They issued a “buy” rating and a $100.00 target price on the stock. SunTrust Banks upped their target price on Ingevity from $90.00 to $92.00 and gave the company a “buy” rating in a research note on Monday, June 25th. Jefferies Financial Group upped their target price on Ingevity to $102.00 and gave the company a “buy” rating in a research note on Tuesday, July 17th. Finally, Zacks Investment Research raised Ingevity from a “hold” rating to a “buy” rating and set a $111.00 target price on the stock in a research note on Monday, July 30th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $101.44.
Ingevity Company Profile
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems.
Read More: Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.